In evaluating bone disorders, which enzyme is primarily measured?

In evaluating bone disorders, which enzyme is primarily measured?

• A. LD
• B. GGT
• C. ALP
• D. AST

Answer: (C)

In the evaluation of bone disorders, the primary enzyme measured is alkaline phosphatase (ALP). This enzyme is found in various tissues but is particularly concentrated in the liver, bones, kidneys, and bile ducts. In the context of bone disorders, elevated levels of ALP indicate increased osteoblastic activity, which occurs during bone formation or when there is increased remodeling due to conditions such as osteomalacia, Paget's disease, or bone metastasis.

ALP is a sensitive marker for bone diseases because its levels can reflect various physiological processes, such as growth, healing, and turnover of bone tissue. When evaluating patients with suspected bone disorders, clinicians rely on ALP levels to assess the activity status of bone metabolism.

The other enzymes listed, such as lactate dehydrogenase (LD), gamma-glutamyl transferase (GGT), and aspartate aminotransferase (AST), are not specific indicators of bone metabolism. LD is involved in the energy production pathway and is more indicative of tissue damage or hemolysis. GGT is more correlated with liver function and is primarily used to assess liver and biliary dysfunction. AST, while also related to liver function, can be elevated in various conditions affecting the